Literature DB >> 16096163

Aging in Asia: a cultural, socio-economical and historical perspective.

Victor H H Goh1.   

Abstract

Asia has about 60% of the world population and population aging is occurring more rapidly in Asia than in Western countries. The group aged 65 years and above will increase from 207 million in 2000 to 857 million in 2050, a staggering increase of 314%. The diversity in economic, demographic, religious, cultural and geo-political factors in Asia is unparalleled by any other continent, and is, in part, contributory to the rapid rise in population aging. By 2050, those under 15 years old will have shrunk from 30% in 2000 to 19%, while those aged 65 years and above will increase from 6% to 18%. In addition, the gender divide still persists with 100 elderly women to 70 elderly men. These projected demographic changes pose three major challenges: 1) how best to address the rising population of the group aged 65 years and above, 2) how to address the shrinking population of the young as well as the working adults, and 3) how to address the problems arising from the disproportionate increase in older women than men. From now to 2050, it will be expeditious for each country in Asia to look into ways of reversing the decline in total fertility rates (TFRs) and restore to replacement levels. If not, at least introduce measures to halt its free fall. Due to the complexity of factors that have influenced the fall in TFRs in Asia, it will be a daunting task to reverse this fall. There is no "single size fits all" solution to this complex problem. Research work in this short-term strategy in addressing the aging population is urgent. In the longer term, the East-West Centre have suggested four modalities, 1) establish policies and programmes that enhance traditional Asian systems of family support for the elderly; 2) introduce policy reform that encourages the elderly who are still capable of remaining in the work force; 3) create institutions and systems that support high levels of personal saving; and 4) formulate public programmes, including pension schemes and national healthcare systems. We need to work while there is time.

Entities:  

Mesh:

Year:  2005        PMID: 16096163     DOI: 10.1080/13685530500088472

Source DB:  PubMed          Journal:  Aging Male        ISSN: 1368-5538            Impact factor:   5.892


  5 in total

1.  Effect of age stratification on the association between carotid intima-media thickness and cognitive impairment in Chinese hypertensive patients: new insight from the secondary analysis of the China Stroke Primary Prevention Trial (CSPPT).

Authors:  Junpei Li; Ling Guo; Lishun Liu; Chengzhang Liu; Lijing Ye; Yun Song; Genfu Tang; Binyan Wang; Xianhui Qin; Yan Zhang; Jianping Li; Ping Li; Huihui Bao; Yanqing Wu; Xiping Xu; Xiaobin Wang; Yong Huo; Xiao Huang; Xiaoshu Cheng
Journal:  Hypertens Res       Date:  2021-09-07       Impact factor: 3.872

Review 2.  Hypertension and Dementia: A comprehensive review from the HOPE Asia Network.

Authors:  Yuda Turana; Jeslyn Tengkawan; Yook Chin Chia; Satoshi Hoshide; Jinho Shin; Chen-Huan Chen; Peera Buranakitjaroen; Jennifer Nailes; Sungha Park; Saulat Siddique; Jorge Sison; Arieska Ann Soenarta; Jam Chin Tay; Guru Prasad Sogunuru; Yuqing Zhang; Ji-Guang Wang; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-05-27       Impact factor: 3.738

3.  Forensic aspect of elder abuse: risk factors and characteristics.

Authors:  Arash Ghodousi; Safa Maghsoodloo; Seyed Mohsen Sadat Hoseini
Journal:  J Res Med Sci       Date:  2011-12       Impact factor: 1.852

4.  Trends in mortality rates of cutaneous melanoma in East Asian populations.

Authors:  Ling Chen; Shaofei Jin
Journal:  PeerJ       Date:  2016-12-22       Impact factor: 2.984

5.  Rhythm-centred music making in community living elderly: a randomized pilot study.

Authors:  Angela Frances Yap; Yu Heng Kwan; Chuen Seng Tan; Syed Ibrahim; Seng Bin Ang
Journal:  BMC Complement Altern Med       Date:  2017-06-14       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.